Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Clin Med (Lond) ; 22(5): 403-408, 2022 09.
Article in English | MEDLINE | ID: covidwho-2056337

ABSTRACT

As the COVID-19 pandemic continues to evolve, different clinical manifestations are better understood and studied. These include various haematologic disorders that have been shown to be associated with increased morbidity and mortality. We studied the prevalence of one unusual manifestation, heparin-induced thrombocytopenia (HIT) and its clinical implications in patients who are severely ill with COVID-19 in a single tertiary centre in Israel. The presence of thrombocytopenia, disseminated intravascular coagulation (DIC) and HIT, and their association with clinical course and outcomes were studied. One-hundred and seven patients with COVID-19 were included. Fifty-seven (53.2%) patients developed thrombocytopenia, which was associated with the worst outcomes (ventilation, DIC and increased mortality). Sixteen (28.0%) patients with thrombocytopenia were positive for HIT, all of which were supported by extracorporeal devices. HIT was independently associated with ventilation days, blood product transfusions, longer hospitalisation and mortality.Platelet abnormalities and HIT are common in patients who are critically ill with COVID-19 and are associated with the worst clinical outcomes. The mechanisms underlying HIT in COVID-19 are yet to be studied; HIT may contribute to the dysregulated immunologic response associated with COVID-19 critical illness and may play a significant part in the coagulopathy seen in these patients. As many patients with COVID-19 require aggressive thromboprophylaxis, further understanding of HIT and the implementation of appropriate protocols are important.


Subject(s)
COVID-19 , Thrombocytopenia , Venous Thromboembolism , Humans , Critical Illness , Heparin/adverse effects , Anticoagulants/adverse effects , Pandemics , COVID-19/complications , Thrombocytopenia/chemically induced , Thrombocytopenia/epidemiology
2.
J Card Surg ; 36(4): 1566-1568, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1059392

ABSTRACT

Acute aortic dissection and acute pulmonary embolism (PE) are life-threatening emergencies that can mimic each other at presentation. Immediate and accurate diagnosis of these scenarios is crucial to initiate the appropriate interventions. In this case report we present a 73-year-old patient, who was admitted to our Medical Center with acute type A aortic dissection. She was tested for coronavirus disease 2019 (COVID-19) infection and was found to be positive. During her admission in the COVID-19 designated intensive care unit, she diagnosed with acute PE in the main right and left pulmonary arteries. She underwent surgery that included bilateral pulmonary embolectomy and aortic dissection repair. The patient was discharged from our hospital on the ninth postoperative day without any complications. Frequency of simultaneous presentation of acute aortic dissection and acute PE is increased with a history of coagulation abnormalities as seen in patients with COVID-19.


Subject(s)
Aortic Aneurysm/surgery , Aortic Dissection/surgery , COVID-19/diagnosis , Aged , Aortic Dissection/diagnostic imaging , Aortic Aneurysm/diagnostic imaging , Computed Tomography Angiography , Embolectomy , Female , Humans , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/surgery
SELECTION OF CITATIONS
SEARCH DETAIL